TLDR

TLDR 2025-08-08

6 sections18 entrieslinks blockcomplete parse

Parse notes

  • Subscription/account footer truncated before parsefooter_truncated

01GENERAL

Sponsored

In a live webinar next Thursday [4], Sapient Insights will share their latest research showing HR leaders aren't just supporting tech decisions—they're shaping them. From AI governance to workforce alignment, HR is playing a key role in enterprise tech strategy.

betterworks.registration.goldcast.ioSponsor

02BIG TECH & STARTUPS

OPENAI LAUNCHES GPT-5 FREE TO ALL CHATGPT USERS

OpenAI has announced GPT-5 in three variants: GPT-5 Pro, GPT-5 mini, and GPT-5 nano. Some of the models will be available across all ChatGPT, including for free users. OpenAI claims the new model family comes with reduced confabulations, improved coding capabilities, and a new approach to handling sensitive requests. Free users now have access to a simulated reasoning AI model. GPT-5 Pro is replacing o3-pro in ChatGPT for those subscriber tiers with access to it.

arstechnica.com7 min read

MEET TBD LAB, META'S SUPERINTELLIGENCE SWAT TEAM

Meta's TBD Lab houses many of the researchers the company lured away from rival labs. It is spearheading Work on the newest version of Meta's large language model, Llama. The TBD Lab will work alongside Meta's other AI teams on a variety of projects. Meta has to date poached at least 18 researchers from OpenAI and a number from Google.

links.tldrnewsletter.com5 min read

03SCIENCE & FUTURISTIC TECHNOLOGY

FDA APPROVES BREAKTHROUGH EYE DROPS THAT FIX NEAR VISION WITHOUT GLASSES

The US Food and Drug Administration has approved an eye drop that improves near vision in adults with presbyopia, a condition that causes near-sighted vision loss. The aceclidine-based eye drops offer relief from blurry near vision for up to 10 hours. They work by gently shrinking the pupil of the eye, creating a pinhole effect that helps bring nearby objects into sharper focus. The eyedrops do not significantly affect the eye's focusing muscles, so using them doesn't blur distance vision or cause myopic shift.

newatlas.com6 min read

ELI LILLY SAYS ITS NEW WEIGHT-LOSS PILL IS HIGHLY EFFECTIVE

Eli Lilly has developed a new pill that causes obese people to lose significant amounts of weight. The drug targets GLP-1, potentially increasing access to GLP-1 medications due to price and ease of application. Its side effect profile is similar to that of the injectable GLP-1 drugs. Eli Lilly plans to file for approval for the drug by the end of the year.

time.com5 min read

04PROGRAMMING, DESIGN & DATA SCIENCE

GPT-5

GPT-5 rarely screws up and generally feels competent. The model used in ChatGPT is a hybrid that switches between different models. GPT-5 is available as three models in the API: regular, mini, and nano. Each can be run at one of four reasoning levels. This post looks at the key characteristics of the models, how they are priced, and what can be learned from the GPT-5 system card.

simonwillison.net13 min read

BUILT WITH BORROWED HANDS

Ignore the claims about vibe coding or that you don't need to know how to write code, and instead look for ways to augment what you do. Experiment with AI and discover what value you can extract - there's a lot of grift. Learn for yourself what works and what doesn't. AI in its current form won't ever replace hands-on-keyboards, and it won't replace engineering.

cra.mr14 min read

05MISCELLANEOUS

THE NEXT PARENTING TREND STARTS BEFORE CONCEPTION

Orchid is a company that lets parents genetically test embryos before pregnancy. Parents can choose their future baby for as little as $2,500. This article features a transcript of an interview with the company's founder, where they debate the scientific, moral, and ethical implications of designing a 'healthy' child and what we lose in separating reproduction from sex. With Orchid's technology, parents in the future will not have to roll the dice with their child's health.

links.tldrnewsletter.com132 min read

INTEL'S CEO, UNDER ATTACK FROM TRUMP, IS ALREADY AT ODDS WITH HIS BOARD

Intel's Chief Executive Lip-Bu Tan and some Intel directors disagree on topics as central as whether the company should stay in the manufacturing business or exit it entirely. Tan recently tried to raise new capital to acquire an artificial intelligence company, but efforts have been stalled by people on the board. Despite Trump unexpectedly calling for Tan's ouster, the company is so far standing by Tan, saying that the board and Tan are all deeply committed to advancing US national and economic security interests. While Intel's chip factories are a money loser, some view them as politically important because they help secure the US semiconductor supply chain.

links.tldrnewsletter.com7 min read